Tag: Suzectrigine

Approved by the FDA in January 2025, suzetrigine (brand name Journavx) offers a non-opioid alternative for acute pain relief. However, like all medications, it is not suitable for everyone. Understanding **who should not take suzetrigine** is crucial for patient safety and preventing serious adverse effects.

Journavx (suzetrigine) was officially approved by the FDA as a prescription-only medication in January 2025, confirming it is not available for purchase over the counter. This non-opioid drug is specifically indicated for the treatment of moderate-to-severe acute pain in adults and requires a doctor's oversight to ensure safe and effective use.